Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added, and the government funding lapse notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center status with a link to opm.gov for updates, and updated the revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T23:04:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    UI and footer metadata updates: added a 'Show glossary' label, corrected capitalization of 'Last Update Submitted that Met QC Criteria', and updated the footer to include 'No FEAR Act Data' and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-27T22:34:31.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Software template revision updated from v3.3.3 to v3.3.4. No study content or user-facing layout changes are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T00:31:00.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page adds a Revision: v3.3.3 label and removes the HHS Vulnerability Disclosure and Revision: v3.3.2 links from the footer. These are administrative site updates with no impact on study content or user interaction.
    Difference
    0.1%
    Check dated 2025-12-23T08:10:51.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.